Thorium-228 Sovereign Manufacturing Capability
Sector: Government • Location: Queensland, Australia
Source: Inside State Government
Establishment of Australia's first sovereign manufacturing capability for Thorium-228, a critical upstream isotope used in next-generation targeted alpha therapies to treat cancer. The project will position Queensland as a global leader in the production of targeted alpha therapies and create 79 new jobs.
- Status
- Closed
- Sector
- Government, Manufacturing (Industrial)
- Location
- Queensland, Australia
- Updated
- 22 Jul 2026
- Source
- Inside State Government
ConstructChat
Ask ConstructChat about Thorium-228 Sovereign Manufacturing Capability
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | awarded |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Establishment of Australia's first sovereign manufacturing capability for Thorium-228, a critical upstream isotope used in next-generation targeted alpha therapies to treat cancer. The project will position Queensland as a global leader in the production of targeted alpha therapies and create 79 new jobs. |
Original sector | Health |
Budget |
Location
Country | Australia |
State | Queensland |
Source
Source | Inside State Government |
URL |
More Details
Record type | Project |
Sector | Government, Manufacturing (Industrial) |
Article published date | 2026-05-12 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project